Stevanato Group S.p.A.
Stevanato Group S.p.A.
Your view on STVN
Overview
What the company does, where it operates, and who runs it.
About Stevanato Group S.p.A.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Franco Stevanato
- Headquarters
- Via Molinella, 17, Piombino Dese, PD, IT
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Franco Stevanato
- Headquarters
- Via Molinella, 17, Piombino Dese, PD, IT
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare.
Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A.
operates as a subsidiary of Stevanato Holding S.R.L.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Stevanato Group S.p.A., and the rating behind it. STVN last traded at $20.90, 37.9× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Stevanato Group S.p.A.. Starting points for Stevanato Group S.p.A.: P/E 37.9, EPS $0.49, beta 0.75 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Stevanato Group S.p.A.. Stevanato Group S.p.A. paid $0.06 per share over the last year — a 0.3% yield at the current $20.90 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Stevanato Group S.p.A.. Trailing twelve-month EPS for Stevanato Group S.p.A. stands at $0.49. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Stevanato Group S.p.A.. Stevanato Group S.p.A. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Stevanato Group S.p.A. valued side by side against its closest peers. Stevanato Group S.p.A. is measured against Medical - Instruments & Supplies peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Stevanato Group S.p.A., and how their positions are changing. At a $5.71B market value, institutional positions materially move Stevanato Group S.p.A.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Stevanato Group S.p.A. executives and directors. Shares of Stevanato Group S.p.A. have traded between $17.76 and $28.00 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Stevanato Group S.p.A.. Stevanato Group S.p.A. is a $5.71B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Stevanato Group S.p.A.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Stevanato Group S.p.A.. Coverage tracks Stevanato Group S.p.A. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.